- $13.46bn
- $30.51bn
- $15.43bn
- 71
- 86
- 59
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11,501 | 11,946 | 17,886 | 16,263 | 15,427 |
Cost of Revenue | |||||
Gross Profit | 4,552 | 4,542 | 6,560 | 7,033 | 6,732 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10,796 | 12,174 | 17,928 | 14,652 | 14,685 |
Operating Profit | 705 | -228 | -42 | 1,611 | 742 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 154 | -721 | -664 | 2,813 | 203 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16.8 | -670 | -1,269 | 2,079 | 54.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 16.8 | -670 | -1,269 | 2,079 | 54.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 16.8 | -670 | -1,269 | 2,079 | 54.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.18 | 0.713 | 0.054 | 2.42 | 0.537 |
Dividends per Share |